Mirum Pharmaceuticals Inc
MIRM
Market Cap$2.19B
Close$
$27.50
39.3% downside
Current Fair Value
39.3% downsideOvervalued by 39.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.19 Billion |
|---|---|
| Enterprise Value | $2.29 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.85 |
| Beta | 0.96 |
| Outstanding Shares | 48,338,096 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -24.33 |
|---|---|
| PEG | 61.37 |
| Price to Sales | 7.55 |
| Price to Book Ratio | 11.32 |
| Enterprise Value to Revenue | 7.45 |
| Enterprise Value to EBIT | -25.98 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 1.41 |
Revenue Sources
No data
Insider Trades
ESG Score
No data